News
Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...
The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...
Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
Weight-loss jabs will be made available to the poorest who have the highest need, the Government has said in the NHS 10-year ...
5d
Verywell Health on MSNWhat Happens to Your Body When You Drink an Aperol SpritzMedically reviewed by Karina Tolentino, RD The Aperol spritz has gained a reputation for being a healthier alternative to other cocktails. However, this drink, made with Aperol liqueur and prosecco ...
Experts have shared their thoughts on the impacts that GLP-1 medications such as Ozempic can have on libido as a side effect ...
For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...
Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...
Q: I have been caring for my 75-year-old husband with dementia for the past four years (I am 72), and I’m at my wits’ end. Suggestions? — Carey T., Joplin, ...
Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead to the loss of vision, according to the EU medicines regulator.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results